ProSomnus Sleep Technologies and MonitAir have announced a collaboration to connect oral appliance therapy (OAT) device data with MonitAir's remote patient monitoring infrastructure, targeting improved outcomes for patients with obstructive sleep apnea (OSA). The integration is designed to support value-based care models by giving clinicians continuous visibility into patient adherence and therapy performance outside the clinic setting.
The functional significance of the pairing lies in data continuity. ProSomnus precision OAT devices already capture in-mouth usage metrics; routing that data through MonitAir's monitoring platform creates a longitudinal record that payers and care teams can use to verify clinical endpoints — a capability that has historically been limited in the oral appliance category relative to CPAP. For the nutraceutical and functional food sector, the development is a signal: sleep-adjacent health technology is consolidating around measurable, outcomes-driven frameworks that finished-formulation brands will increasingly need to align with when positioning sleep-support SKUs to healthcare channels.
Sleep health represents one of the fastest-growing segments within the broader functional wellness market. Consumer demand for products targeting sleep latency, sleep quality, and next-day cognitive performance has driven category expansion across melatonin, L-theanine, magnesium glycinate, ashwagandha standardized extracts, and adaptogen blends. As connected care infrastructure matures around OSA specifically — a condition affecting an estimated 1 billion adults globally — ingredient suppliers and brand formulators have an opportunity to position complementary nutraceutical protocols within multidisciplinary sleep care pathways. Operators exploring that channel should note the regulatory boundary: structure-function claims tied to sleep remain permissible under DSHEA, but co-marketing with medical devices requires careful substantiation review.
Distribution context matters here. The ProSomnus-MonitAir integration is aimed squarely at dental sleep medicine practices and health system sleep programs — precisely the provider touchpoints where functional food and supplement brands have struggled to gain credentialed shelf presence. Brands with clinical data supporting sleep-onset or sleep-maintenance claims, and the white-label or co-manufacturing capacity to private-label for healthcare groups, are best positioned to benefit from this convergence. The collaboration underscores a broader industry shift: sleep is moving from a consumer wellness play toward a clinically managed condition with reimbursable digital infrastructure wrapped around it.
For nutraceutical operators tracking adjacent category dynamics, this is a moment to audit sleep-support portfolios against clinical-grade evidence standards. Brands that can present peer-reviewed, double-blind, placebo-controlled trial data — and express outcomes in the numeric terms value-based care demands — will find the healthcare sleep channel increasingly accessible. Those relying solely on anecdotal or traditional-use substantiation may find the door narrowing. Coverage of sleep-ingredient clinical development and adaptogen market trends continues to be a priority area, as does sleep supplement formulation guidance for operators building into this channel.
Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.
